Quitting ecstasy: An investigation of why people stop taking the drug and their subsequent mental health

Journal of Psychopharmacology

Volumn 17, Issue 4, 2003, Pages 371-378

  Verheyden, Suzanne L ^a   Maidment, Rachel ^a   Curran, H Valerie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aggression; Depression; Ecstasy; Ex users; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; AGGRESSION; ANGER; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DEPRESSION; DRUG WITHDRAWAL; HOSTILITY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HEALTH; MOOD DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF MEDICATION; TELEPHONE;

ADULT; AFFECT; AGGRESSION; AMPHETAMINE-RELATED DISORDERS; ANXIETY; DECISION MAKING; HALLUCINOGENS; HUMANS; INTERVIEWS; MENTAL DISORDERS; MENTAL HEALTH; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POSTAL SERVICE; QUESTIONNAIRES;

EID: 0042402982     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881103174014     Document Type: Article

References (39)

1. Barratt E S, Patton J H (1983) Impulsivity: cognitive, behavioural and psychophysiological correlates. In Zucherman M (ed.), Biological basis of sensation feeling, impulsivity and anxiety. Lawrence Erlbaum Associates Inc., Hillsdale, New Jersey
2. 3H] paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Therapeut 242: 911-916
3. Beck A T (1978) The Beck Depression Inventory (BDI). The Psychological Corporation; Harcourt Brace Jovanovitz Inc., San Antonio, Orlando
4. Brown G W, Andrews B, Harris T, Adler Z, Bridge L (1986) Social support, self-esteem and depression. Psychol Med 16: 813-831
5. Buss A H, Perry M (1992) The aggression questionnaire. J Personal Soc Psychol 63: 452-459
6. Cole J C, Sumnall H R, Wagstaff G F (2002) What is a dose of Ecstasy? J Psychopharmacol 16: 189-190
7. Croft R J, Mackay A J, Mills A T, Gruzelier J G (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology (Berl) 153: 373-379
8. Curran H V, Travill R A (1997) Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): weekend high followed by mid-week low. Addiction 92: 821-831
9. Curran H V (2000) Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 42: 34-41
10. Curran H V, Verheyden S L (2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (Ecstasy) is highly correlated with human memory function. Psychopharmacology 169: 91-103
11. Davis W M (1996) Psychopharmacologic violence associated with cocaine abuse: kindling of a limbic dyscontrol syndrome? Prog Neuropsychopharmacol Biol Psychiatry 20: 1273-1300
12. Denison M E, Paredes A, Booth J B (1997) Alcohol and cocaine interactions and aggressive behaviors. Recent Dev Alcohol 13: 283-303
13. Frackiewicz E J, Sramek J J, Cutler N R (2000) Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother 34: 80-88
14. Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi G F, Delsignore R, Brambilla F (2000) Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol Psychiatry 47: 127-136
15. Grob C S (2000) Deconstructing ecstasy: the politics of MDMA research. Addict Res 8: 549-588
16. Hatzidimitriou G, McCann U D, Ricaurte G A (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19: 5096-5107
17. Heatherton T F, Polivy J (1991) Development and validation of a scale for measuring state self-esteem. J Personal Soc Psychol 60: 895-910
18. Horan B, Gardner E L, Ashby C R (2000) Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4-methylenedioxymethamphetamine (MDMA). Synapse 35: 160-162
19. Jansen K L R (1999) Ecstasy (MDMA) dependence. Drug Alcohol Depend 53: 121-124
20. Lieb R, Schuetz C G, Pfister H, von Sydow K, Wittchen U (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68: 195-207
21. MacInnes N, Handley S L, Harding G F A (2001) Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol 15: 181-186
22. McCann U D, Szabo Z, Scheffel U, Dannals R F, Ricaurte G A (1998) Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings. Lancet 352: 1433-1437
23. McKenna D J, Peroutka S J (1990) Neurochemistry and neurotoxicity of 3,4 methylenedioxymethamphetamine (MDMA, 'ecstasy'). J Neurochem 54: 14-22
24. Morgan M J (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152: 230-248
25. Morgan M J, McFie L H, Robinson J A (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159: 294-303
26. NIDA (2001) National Survey Results on Drug Use from the Monitoring the Future Study, 1975-2000: Volume II, College Students and Young Adults. National Institute on Drug Abuse (NIDA) Report: NCADI#BKD422
27. Parrott A C, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 139: 261-268
28. Prochaska J O, DiClemente C (1986) Toward a comprehensive model of change. In Miller H (eds), Treating addictive behaviours. Plenum Press: New York
29. Ricaurte G A, Yuan J, McCann U D (2000) (±3,4 methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42: 5-10
30. Ricaurte G A, Yuan J, Hatzidimitriou G, Cord B J, McCann U D (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ('ecstasy'). Science 297: 2260-2263
31. Saunders N (1995) Ecstasy and the dance culture. Neal's Yard Desktop Publishing Studio, London
32. Schechter M D (1998) 'Candyflipping': synergistic discriminative effect of LSD and MDMA. Eur J Pharmacol 341: 131-134
33. Semple D M, Ebmeier K P, Glabus M F, O'Carroll R E, Johnstone E C (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry 175: 63-69
34. Siegel J M (1986) The Multidimensional Anger Inventory. J Personal Soc Psychol 51: 191-200
35. Spielberger C, Garsuch R, Lushene R (1970) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA
36. Topp L, Hando J, Dillon P, Roche A, Solowij N (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105-115
37. Verheyden S L, Hadfield J, Calin T, Curran H V (2002) Sub-acute effects of MDMA (±3,4 methylenedioxymethamphetamine, 'ecstasy') on mood: evidence of gender differences. Psychopharmacology 161: 23-31
38. Verheyden S, Henry J, Curran H V (2003) Acute, sub-acute and long-term subjective consequences of ecstasy (MDMA) consumption in 430 regular users. Hum Psychopharmacol: Clin Experiment, in press
39. Zigmond A S, Snaith R P (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67: 361-370